About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT06706609

Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population

This study aims to classify adult-onset diabetes patients into distinct data-driven clusters, such as severe insulin-deficient, severe insulin-resistant, mild obesity-related, and mild age-related dia...

Lead sponsor: Getz Pharma•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Dr Shaheryar Hasan, MBBS, MBA

CONTACT

+923121260642 [email protected]

Dr Jahanzeb Kamal Khan, MBBS, MBA, CRCP, MCPS

CONTACT

+923201212945 [email protected]

Sponsors

Lead Sponsor

Getz Pharma

Age

16 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients of both genders whose age of disease onset was older than 16 years
•Patients newly diagnosed with or previously diagnosed with T2D
•Able and willing to provide written informed consent and to comply with the study

Exclusion Criteria

•Patients with other medical comorbidities (not a complication of diabetes), such as malignancies.
•Pregnancy

Related studies

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

RECRUITINGPhase 1

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

NCT07535307 · Diabetes Mellitus

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients

NCT07536516 · Diabetes Mellitus

RECRUITINGPhase 3

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

NCT07222137 · Diabetes Mellitus, Type 1

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 26, 2024Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment394

Start dateFeb 2025

Last updatedNov 26, 2024

Condition

Diabetes Mellitus Diabetes Mellitus, Adult-Onset Diabetes Mellitus Type 1 and 2

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 26, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions